Project Grant K99AG086525

Award Date 9/20/24
Completion Date 8/31/25
Dollars Obligated $255K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,359,000.00 to Baylor College of Medicine to conduct research on age-associated cellular and molecular adaptations that enable whole-organism rejuvenation in the highly regenerative flatworm Schmidtea mediterranea. The research aims to (1) determine how age-associated damage manifests in asexual planaria throughout their lifecycle...
This Project Grant award of $132,705 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) is supporting research to understand metabolic alterations in hematopoietic stem and progenitor cells (HSPCs) that contribute to hematopoietic clonal dominance and associated diseases during aging. The key objectives are to: 1) identify metabolic differences between dominant and non-dominant HSPC clones in aging using single-cell metabolomics and genetic barcoding in a...
This National Institute on Aging (CFDA 93.866 Aging Research) Project Grant award of $412,500 to the Trustees of Boston University (Boston University Medical Campus) will fund research to investigate the "vicious cycle" between disruption of chromatin architecture, activation of retrotransposable elements (RTEs), and misexpression of CpG island-deficient genes during the aging process. The research aims to validate the mutual activation between chromatin architecture disruption and RTE...
The National Institute on Aging (NIA) awarded a $333,116 Project Grant under the Aging Research federal grant program (CFDA 93.866) to The Trustees of the University of Pennsylvania (UPenn) on September 1, 2025. The project, titled "Aging and Telomere Dysfunction in the Intestinal Stem Cell Niche", aims to investigate how aging and telomere dysfunction impact the function of intestinal stem cell niches. Specifically, the research will focus on understanding the role of subepithelial...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $437,366 to the University of Louisville to conduct research on the effects of lipid metabolism on stem cell niche homeostasis. The objective is to understand how age-related changes in lipid accumulation and signaling pathways impact the maintenance and function of stem cell niches, with a focus on the Drosophila testis model. The research will test if suppressing the activation of key lipid...
The National Institute on Aging (NIA) awarded a $442,750 Project Grant (CFDA 93.866) to Duke University to conduct research on using heterochronic (age-mismatched) hepatocyte transplantation to rejuvenate the aged liver. The research aims to understand how transplanting young hepatocytes into old livers, and vice versa, can influence liver function, cellular composition, and the plasma proteome. Key objectives include measuring changes in liver function markers, analyzing the liver's cellular...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $378,750 in funding to Saint Louis University to conduct research on the role of cytosolic DNA-induced sterile inflammation in driving cellular and organismal progeria/aging hallmarks. The key objectives are to: 1) define the non-canonical mode of STING stimulation upon progerin-induced accumulation of cytosolic DNA, 2) examine how STING, STAT1, and downstream interferon-stimulated genes like...
This $451,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund research by The University of Texas Southwestern Medical Center to investigate the role of the p38 MAPK signaling pathway in regulating lysosome function and tissue integrity during development and aging. The key goals of this 2-year project are to: 1) define the p38 MAPK interactome required for lysosome regeneration, 2) reveal tissue and stage-specific functions of p38 MAPK...
The University of Chicago was awarded a $464,212 Project Grant by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The 5-year grant, effective August 1, 2025, will fund research to characterize the genetic and biological mechanisms underlying the extensive pleiotropy (multiple phenotypic effects) associated with a genomic region on chromosome 5p15.33 that impacts cancer risk, telomere length, epigenetic aging, and other aging-related...
This Project Grant award of $506,404.00 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate mechanisms of local and global epigenetic changes that drive senescence and aging-associated phenotypes. Key research objectives include: Examining how enhancers are rewired during senescence and aging, focusing on large enhancer communities or "cliques" and identifying transcription factors that drive their formation....

BALANCING CELLULAR REPAIR AND REGENERATION IN AGING AND DISEASE - PROJECT SUMMARY/ABSTRACT BACKGROUND: AGING IS AN INCREDIBLY PLASTIC PROCESS THAT IS DICTATED BY COORDINATED REPAIR AND REGENERATIVE MECHANISMS. LOSS OF THIS COORDINATION MARKS THE START OF TISSUE DECLINE AND AGING, THEREBY INCREASING DISEASE SUSCEPTIBILITY. ALARMINGLY, AGE-DEPENDENT DISEASES ARE DISPROPORTIONATELY RISING IN YOUNG AGE GROUPS WITHOUT KNOWN CAUSE. EARLY-AGE ONSET COLORECTAL CANCER (EAO CRC) IS A PRIME EXAMPLE, WHICH AFRICAN AMERICANS EXPERIENCE THE HIGHEST DISEASE BURDEN. RATIONALE: PREVIOUSLY, WE DISCOVERED A NOVEL HEDGEHOG (HH)-DEPENDENT MECHANISM THAT BALANCES CELLULAR REPAIR AND REGENERATION TO SUSTAIN HEALTHY TISSUE AGING. SPECIFICALLY, WE IDENTIFIED THE HH EFFECTOR PATCHED (PTC) AS A CRITICAL SWITCH FOR BALANCING AUTOPHAGY-BASED CELLULAR REPAIR AND HH-DEPENDENT REGENERATIVE PROLIFERATION. IMPORTANTLY, LOSS OF PTC FUNCTION DRIVES ACCELERATED CELLULAR AGING. HYPOTHESIS: WE PROPOSE THAT THE CELLS ARE AGING RAPIDLY RELATIVE TO CHRONOLOGICAL AGE, DUE TO THE LOSS OF THIS HH-DEPENDENT COORDINATION OF AUTOPHAGY AND PROLIFERATION. WE PREDICT FACTORS THAT PROMOTE ABERRANT HH SIGNALING PREDISPOSE INDIVIDUALS TO EAO CRC ONSET. SPECIFIC AIMS: TO TEST THIS HYPOTHESIS, I WILL DELINEATE THE MECHANISM OF HH SIGNALING IN BALANCING AUTOPHAGY AND PROLIFERATION TO PRESERVE CELLULAR AGING (AIM 1); DEFINE THE HH-DEPENDENT TRANSCRIPTOME DURING AGING, WITH A PARTICULAR INTEREST IN IDENTIFYING GENES THAT ARE DYSREGULATED IN CANCERS IMPACTING AFRICAN AMERICANS (AIM 2); AND FUNCTIONALLY TEST THE INTERSECTION OF HH SIGNALING AND GENETIC DETERMINANTS OF CANCER DISPARITIES USING BOTH THE DROSOPHILA INTESTINES MODEL AND PATIENT-DERIVED COLON ORGANOIDS (AIM 3). THIS STUDY WILL PRECISELY DEFINE FUNDAMENTAL MECHANISMS AND AGING-DEPENDENT CELLULAR MARKERS THAT ARE APPLICABLE TO DISEASES IMPACTING AFRICAN AMERICAN COMMUNITIES. THE CULMINATION OF THIS INVESTIGATION WILL HONE THE REQUIRED KNOWLEDGE, TECHNICAL SKILLSETS, AND PROFESSIONAL NETWORKS TO SUCCESSFULLY LAUNCH MY INDEPENDENT RESEARCH PROGRAM, FOCUSED ON ELUCIDATING REGULATORS OF THE AUTOPHAGY-PROLIFERATION BALANCE TO REDUCE AGING-RELATED DISEASE DISPARITIES.

Posted 9/20/24